Contact
searchSearch
HMP Global

Rheumatoid Arthritis Specialty Channel

News
Machine Learning Models Identify Patients With Rheumatoid Arthritis At Risk for Treatment Nonadherence
03/20/2026
Lisa Kuhns, PhD, MD
Machine learning models may help clinicians pinpoint which older patients with rheumatoid arthritis are most likely to fall off therapy—before it happens.
Machine learning models may help clinicians pinpoint which older patients with rheumatoid arthritis are most likely to fall off therapy—before it happens.
Machine learning models may help...
03/20/2026
First Report Managed Care
News
Arthritis Activity Limitations Affect Nearly Half of US Adults
03/06/2026
Grace Taylor, MS, MA
Nearly half of US adults with arthritis reported activity limitations in 2023, underscoring persistent functional burden and missed national targets to reduce disability.
Nearly half of US adults with arthritis reported activity limitations in 2023, underscoring persistent functional burden and missed national targets to reduce disability.
Nearly half of US adults with...
03/06/2026
First Report Managed Care
News
Study Probes Gut Health as Missing Link Between Diet and Rheumatoid Arthritis Activity
02/17/2026
Lisa Kuhns, PhD, MD
A new Arizona-based research project aims to clarify why many people with rheumatoid arthritis (RA) struggle to reach sustained remission by testing whether diet influences disease activity indirectly through gut health and inflammation,...
A new Arizona-based research project aims to clarify why many people with rheumatoid arthritis (RA) struggle to reach sustained remission by testing whether diet influences disease activity indirectly through gut health and inflammation,...
A new Arizona-based research...
02/17/2026
First Report Managed Care
News
Rheumatoid Arthritis Mortality Declines Among US Postmenopausal Women
02/11/2026
Grace Taylor, MS, MA
Rheumatoid arthritis (RA) mortality among US postmenopausal women has declined by more than half since 1999, but persistent racial, regional, and age-based disparities—and a pandemic-related spike—highlight ongoing inequities in outcomes.
Rheumatoid arthritis (RA) mortality among US postmenopausal women has declined by more than half since 1999, but persistent racial, regional, and age-based disparities—and a pandemic-related spike—highlight ongoing inequities in outcomes.
Rheumatoid arthritis (RA)...
02/11/2026
First Report Managed Care
News
US Observational Data Show Variable Real-World Outcomes With JAK Inhibitors in RA
01/19/2026
Juliet Gallagher
Real-world evidence (RWE) is increasingly used to complement randomized controlled trial data in rheumatoid arthritis treatment decision-making. A new study synthesized observational studies evaluating the real-world effectiveness of Janus...
Real-world evidence (RWE) is increasingly used to complement randomized controlled trial data in rheumatoid arthritis treatment decision-making. A new study synthesized observational studies evaluating the real-world effectiveness of Janus...
Real-world evidence (RWE) is...
01/19/2026
First Report Managed Care
News
Specialist Access Eliminates Racial Gaps in Rheumatoid Arthritis DMARD Use
01/12/2026
Lisa Kuhns, PhD, MD
Racial inequities in access to modern rheumatoid arthritis (RA) therapies persist across the United States, but disappear among patients who reach rheumatology care, according to study results published in The Journal of Rheumatology.
Racial inequities in access to modern rheumatoid arthritis (RA) therapies persist across the United States, but disappear among patients who reach rheumatology care, according to study results published in The Journal of Rheumatology.
Racial inequities in access to...
01/12/2026
First Report Managed Care
News
No Increased Multiple Myeloma Risk Found With Biologic or Targeted DMARD Use in Veterans With Rheumatoid Arthritis
10/07/2025
Grace Taylor, MS, MA
A large Veterans Health Administration (VHA) study found no significant difference in multiple myeloma incidence between patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs...
A large Veterans Health Administration (VHA) study found no significant difference in multiple myeloma incidence between patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs...
A large Veterans Health...
10/07/2025
First Report Managed Care
Videos
Evolving Strategies in RA Treatment: Real-World Insights and Access Challenges
06/09/2025
Jonathan Kay, MD; Julie Baak; Juliet Gallagher
This expert roundtable, hosted by First Report Managed Care, explores the evolving rheumatoid arthritis (RA) treatment landscape, highlighting advancements in therapeutic options, challenges with payer-driven access and reimbursement, and the...
This expert roundtable, hosted by First Report Managed Care, explores the evolving rheumatoid arthritis (RA) treatment landscape, highlighting advancements in therapeutic options, challenges with payer-driven access and reimbursement, and the...
This expert roundtable, hosted...
06/09/2025
First Report Managed Care
Formulary Frontlines®
Comparative Review of RA Biologics and DMARDs Coverage Across 3 Major Health Plans
05/23/2025
Danielle Sposato; Juliet Gallagher
Our latest Formulary Frontlines report analyzes how Blue Cross Blue Shield, Cigna, and UnitedHealthcare structure coverage for RA biologics and DMARDs, revealing key differences in tiering, utilization management, and biosimilar strategy....
Our latest Formulary Frontlines report analyzes how Blue Cross Blue Shield, Cigna, and UnitedHealthcare structure coverage for RA biologics and DMARDs, revealing key differences in tiering, utilization management, and biosimilar strategy....
Our latest Formulary Frontlines...
05/23/2025
First Report Managed Care
News
Study Highlights Motivators and Barriers to Clinical Trial Enrollment in Rheumatoid Arthritis
05/07/2025
Grace Taylor, MS, MA
New findings reveal what motivates patients with rheumatoid arthritis to participate in clinical trials.
New findings reveal what motivates patients with rheumatoid arthritis to participate in clinical trials.
New findings reveal what...
05/07/2025
First Report Managed Care
Industry Insights
News Conference Coverage
Expert Perspectives
Videos Interview

What's New?

News
Machine Learning Models Identify Patients With Rheumatoid Arthritis At Risk for Treatment Nonadherence
03/20/2026
Lisa Kuhns, PhD, MD
Machine learning models may help clinicians pinpoint which older patients with rheumatoid arthritis are most likely to fall off therapy—before it happens.
Machine learning models may help clinicians pinpoint which older patients with rheumatoid arthritis are most likely to fall off therapy—before it happens.
Machine learning models may help...
03/20/2026
First Report Managed Care
News
Arthritis Activity Limitations Affect Nearly Half of US Adults
03/06/2026
Grace Taylor, MS, MA
Nearly half of US adults with arthritis reported activity limitations in 2023, underscoring persistent functional burden and missed national targets to reduce disability.
Nearly half of US adults with arthritis reported activity limitations in 2023, underscoring persistent functional burden and missed national targets to reduce disability.
Nearly half of US adults with...
03/06/2026
First Report Managed Care
News
Study Probes Gut Health as Missing Link Between Diet and Rheumatoid Arthritis Activity
02/17/2026
Lisa Kuhns, PhD, MD
A new Arizona-based research project aims to clarify why many people with rheumatoid arthritis (RA) struggle to reach sustained remission by testing whether diet influences disease activity indirectly through gut health and inflammation,...
A new Arizona-based research project aims to clarify why many people with rheumatoid arthritis (RA) struggle to reach sustained remission by testing whether diet influences disease activity indirectly through gut health and inflammation,...
A new Arizona-based research...
02/17/2026
First Report Managed Care
News
Rheumatoid Arthritis Mortality Declines Among US Postmenopausal Women
02/11/2026
Grace Taylor, MS, MA
Rheumatoid arthritis (RA) mortality among US postmenopausal women has declined by more than half since 1999, but persistent racial, regional, and age-based disparities—and a pandemic-related spike—highlight ongoing inequities in outcomes.
Rheumatoid arthritis (RA) mortality among US postmenopausal women has declined by more than half since 1999, but persistent racial, regional, and age-based disparities—and a pandemic-related spike—highlight ongoing inequities in outcomes.
Rheumatoid arthritis (RA)...
02/11/2026
First Report Managed Care
News
US Observational Data Show Variable Real-World Outcomes With JAK Inhibitors in RA
01/19/2026
Juliet Gallagher
Real-world evidence (RWE) is increasingly used to complement randomized controlled trial data in rheumatoid arthritis treatment decision-making. A new study synthesized observational studies evaluating the real-world effectiveness of Janus...
Real-world evidence (RWE) is increasingly used to complement randomized controlled trial data in rheumatoid arthritis treatment decision-making. A new study synthesized observational studies evaluating the real-world effectiveness of Janus...
Real-world evidence (RWE) is...
01/19/2026
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use